Back to search

Belgium· BE-AMP-SAM461840-00

Bemfola 300 IU/0.5 ml

A follitropin alfa product containing human follitropin alfa, recombinant, registered in Belgium by Gedeon Richter. The same ATC class is registered in 12 of our 19 countries.

ATC G03GA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedBemfola 300 IU/0.5 mlATCG03GA05REGISTER NO.BE-AMP-SAM461840-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Follitropin alfa is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA05 (follitropin alfa), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Follitropin alfa · ATC G03GA05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Follitropin Alfa, Recombinant
Manufacturer
Gedeon Richter
Country
Belgium (BE)
ATC code
G03GA05
ATC class
Follitropin alfa
Defined daily dose
75 E, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    4653754
  • be_apb
    3205192

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Follitropin alfa in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All follitropin alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Bemfola, Gonal-F
  • Liechtenstein · Bemfola, Gonal-F
  • Norway · Bemfola, Gonal-F

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ab277f12-df27-4d85-8e86-0f9524ec45ca
GET /v1/drugs/ab277f12-df27-4d85-8e86-0f9524ec45ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Bemfola 300 IU/0.5 ml",
  "name_fr": "Bemfola 300 IU/0.5 ml",
  "name_nl": "Bemfola 300 IU/0.5 ml",
  "amp_code": "SAM461840-00",
  "strengths": [
    "300.0000",
    "300.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Human Follitropin Alfa, Recombinant",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Sodium Dihydrogen Phosphate Dihydrate",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Follitropin Alfa",
  "authorisation_numbers": [
    "EU/1/13/909/012",
    "EU/1/13/909/004",
    "EU/1/13/909/013"
  ]
}

See everything about follitropin alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.